BioAge Labs, Inc.
Nasdaq BIOA · Emeryville, CA
Works in Cardiovascular · Hematology · Infectious disease · Metabolic & endocrine · Ophthalmology · Respiratory
BioAge Labs, Inc. is a clinical trial sponsor based in Emeryville, CA, listed as Nasdaq BIOA. It has 2 active clinical trials with 340 planned participants, across 6 therapeutic areas. Since 2021 it has completed 1 trial and stopped 4 early.
Trial track record · since 2021
Financials · Nasdaq BIOA
Fundraising
Pipeline · 2 active trials
| Stage | Trial | Status |
|---|---|---|
Questions about BioAge Labs, Inc
BioAge Labs, Inc is lead sponsor of 2 active clinical trials on ClinicalTrials.gov, with 340 planned participants, in Cardiovascular, Hematology, Infectious disease, Metabolic & endocrine and other areas. Since 2021 it has completed 1 trial and stopped 4 early.
BioAge Labs, Inc is based in Emeryville, CA and is listed as Nasdaq BIOA. The address is the one on its SEC filings, which name the establishment or the registrant, not always the group's head office.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with BioAge Labs, Inc; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-09-10.
Approve Suite is not affiliated with BioAge Labs, Inc..
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.